Packing-Line Improvement Based on a Fault-Tree Analysis Approach - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Packing-Line Improvement Based on a Fault-Tree Analysis Approach
This article focuses on upgrading and improving a packing process to comply with current good manufacturing practices. The authors sought to maintain proper quality assurance for finished products.

Pharmaceutical Technology
Volume 3, Issue 32

Figure 3: Packing-process fault tree showing the main start section and the major unwanted event.
A BP 4100 technical balance (Sartorius, Göttingen, Germany) with a 0–4100-g range and a resolution of ± 0.1 g is located at the end of the line. An operator places each MUB and reads its weight to verify that it has been filled. The MUB is then sealed, and the corresponding label is affixed. Shipping boxes are also checked in the same way using a QC1500NNP scale (Sartorius ) with 0–1500-kg range and ± 200-g resolution. Shipping boxes are then sealed and labeled accordingly.

Figure 4: Packing-process fault tree showing the branch that follows from product temperature-requirement failure.
This arrangement is designed to ensure good coordination among all operators regarding manual performance. The time each packing operator took to complete an MUB, including visual inspection, was measured as 160–170 s, with a margin of 10 s for recovery. The conveyor was therefore set to a linear velocity of 900 cm/min. The labeling machine had an optimum working speed of 45–47 vials/min. Hence, the buffer operator has an important task, which is to control vial distribution through the conveyor at intervals of 12–13 s. The buffer operator avoids bottlenecks by gathering the overflow of labeled vials to operators, and releasing the collected vials when the labeling machine is interrupted.

Fault-tree analysis of the packing process

Figure 5: Packing-process fault tree showing the branch following from failure in primary-information imprinting.
An FTA model was specially developed for the packing process by representing failure events with logical operators to form a logical information flow chart (see Figure 3). The special symbols employed in this flow chart are explained in the literature (7). The major unwanted event was defined as "Finished-product quality noncompliance resulting from packing process." All cause–effect fault events flow downward. Any of the following failures can provoke the major unwanted event:
  • Failure in product temperature requirements during the packing process (which exclusively applies to products that require refrigeration)
  • Failure of packing material to display the corresponding primary product information (e.g., batch manufacturing date, batch number or identification code, and batch expiration date)
  • Lack of correspondence between product specifications, printed packing material (e.g., vial labels, cartons, leaflets, MUBs, and shipping labels), and documentation (e.g., QA release authorizations, packing order, and records created during packaging)
  • Failure to comply with cleaning and line-clearance requirements for areas involved in the packing process, including labeling machine and all workstations, to avoid product-batch cross contamination.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here